CytoMed Therapeutics Limited Ordinary Shares
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $167 | $205 | $134 | $134 |
Gross Profit | -555 | 173 | 125 | 125 |
EBITDA | -2,224 | -995 | -1,026 | -1,025 |
EBIT | -2,356 | -1,097 | -1,116 | -1,115 |
Net Income | -1,730 | -868 | -1,125 | -1,124 |
Net Change In Cash | 167 | 205 | 134 | 134 |
Free Cash Flow | -2,347 | -1,194 | -1,819 | -975 |
Cash | 2,095 | 2,095 | 2,865 | 2,861 |
Basic Shares | 11,788 | 11,754 | 11,809 | 11,809 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $319 | $69 | $509 | $365 |
Gross Profit | -886 | 52 | 505 | -109 |
EBITDA | -4,296 | -2,444 | -3,887 | -1,473 |
EBIT | -4,519 | -2,569 | -3,990 | -1,868 |
Net Income | -3,916 | -2,571 | -4,144 | -3,055 |
Net Change In Cash | 319 | 69 | 509 | 365 |
Free Cash Flow | -4,400 | -4,109 | -3,599 | -1,880 |
Cash | 2,095 | 4,969 | 9,019 | 1,587 |
Basic Shares | 11,647 | 11,539 | 10,630 | 7,915 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-09-30 | -$0.19 |
2025-03-31 | -$0.12 |
2024-09-30 | -$0.04 |